Last updated: November 29, 2023
Sponsor: Katharina Timper
Overall Status: Active - Recruiting
Phase
N/A
Condition
Body Composition
Diabetes Prevention
Weight Loss
Treatment
N/AClinical Study ID
NCT06153654
2021-01090
Ages 18-55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: N=50 adult male and female patients with obesity will be included in this study. Inclusion criteria: Inclusion criteria:
- Age 18-55 years
- Written informed consent
- BMI > 30 kg/m2 N=50 adult lean patients age- and sex-matched to the group of obese patients will beincluded in this study. Inclusion criteria:
- Age 18-55 years
- Written informed consent
- BMI 18-25 kg/m2 N=50 adult male and female patients with obesity with scheduled bariatric will be includedin this study Inclusion criteria:
- Age 18-55 years
- Written informed consent
- BMI > 35 kg/m2
Exclusion
Exclusion Criteria:
- Smoking
- Chronic or acute sinusitis
- Surgical intervention of the nasal cavity or the paranasal sinus
- Use of antibiotics within the last 31 days18
- Current illicit drug abuse including daily marijuana or CBD consumption (≤ 24 g ofalcohol per day allowed)
- Any kind of severe chronic disease (e.g. severe heart failure, active cancer disease)
- Use of any kind of decongestant more than twice a week
- Use of cortisone-containing nasal spray within the last 3 months
- Acute allergic rhinitis
- History of neurodegenerative diseases
- History of severe head trauma
- Severe renal impairment (e.g. estimated glomerular filtration rate <30 ml/min/m2)
Study Design
Total Participants: 150
Study Start date:
July 30, 2021
Estimated Completion Date:
September 30, 2025
Connect with a study center
University Hospital Basel
Basel,
SwitzerlandActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.